EpitulipinolideCAS# 24164-13-4 |
2D Structure
Quality Control & MSDS
3D structure
Package In Stock
Number of papers citing our products
Cas No. | 24164-13-4 | SDF | Download SDF |
PubChem ID | 5322173 | Appearance | Powder |
Formula | C17H22O4 | M.Wt | 290.4 |
Type of Compound | Sesquiterpenoids | Storage | Desiccate at -20°C |
Solubility | Soluble in Chloroform,Dichloromethane,Ethyl Acetate,DMSO,Acetone,etc. | ||
Chemical Name | [(6E,10E)-6,10-dimethyl-3-methylidene-2-oxo-3a,4,5,8,9,11a-hexahydrocyclodeca[b]furan-4-yl] acetate | ||
SMILES | CC1=CC2C(C(CC(=CCC1)C)OC(=O)C)C(=C)C(=O)O2 | ||
Standard InChIKey | UPNVKIZABMRHNR-BBYAVRKXSA-N | ||
Standard InChI | InChI=1S/C17H22O4/c1-10-6-5-7-11(2)9-15-16(12(3)17(19)21-15)14(8-10)20-13(4)18/h6,9,14-16H,3,5,7-8H2,1-2,4H3/b10-6+,11-9+ | ||
General tips | For obtaining a higher solubility , please warm the tube at 37 ℃ and shake it in the ultrasonic bath for a while.Stock solution can be stored below -20℃ for several months. We recommend that you prepare and use the solution on the same day. However, if the test schedule requires, the stock solutions can be prepared in advance, and the stock solution must be sealed and stored below -20℃. In general, the stock solution can be kept for several months. Before use, we recommend that you leave the vial at room temperature for at least an hour before opening it. |
||
About Packaging | 1. The packaging of the product may be reversed during transportation, cause the high purity compounds to adhere to the neck or cap of the vial.Take the vail out of its packaging and shake gently until the compounds fall to the bottom of the vial. 2. For liquid products, please centrifuge at 500xg to gather the liquid to the bottom of the vial. 3. Try to avoid loss or contamination during the experiment. |
||
Shipping Condition | Packaging according to customer requirements(5mg, 10mg, 20mg and more). Ship via FedEx, DHL, UPS, EMS or other couriers with RT, or blue ice upon request. |
Description | 1. Epitulipinolide has antitumor activity. 2. Epitulipinolide diepoxide has antioxidative activity and chemopreventive activity in skin melanoma cells, it can significantly inhibit the proliferation of melanoma cells. |
Epitulipinolide Dilution Calculator
Epitulipinolide Molarity Calculator
1 mg | 5 mg | 10 mg | 20 mg | 25 mg | |
1 mM | 3.4435 mL | 17.2176 mL | 34.4353 mL | 68.8705 mL | 86.0882 mL |
5 mM | 0.6887 mL | 3.4435 mL | 6.8871 mL | 13.7741 mL | 17.2176 mL |
10 mM | 0.3444 mL | 1.7218 mL | 3.4435 mL | 6.8871 mL | 8.6088 mL |
50 mM | 0.0689 mL | 0.3444 mL | 0.6887 mL | 1.3774 mL | 1.7218 mL |
100 mM | 0.0344 mL | 0.1722 mL | 0.3444 mL | 0.6887 mL | 0.8609 mL |
* Note: If you are in the process of experiment, it's necessary to make the dilution ratios of the samples. The dilution data above is only for reference. Normally, it's can get a better solubility within lower of Concentrations. |
Calcutta University
University of Minnesota
University of Maryland School of Medicine
University of Illinois at Chicago
The Ohio State University
University of Zurich
Harvard University
Colorado State University
Auburn University
Yale University
Worcester Polytechnic Institute
Washington State University
Stanford University
University of Leipzig
Universidade da Beira Interior
The Institute of Cancer Research
Heidelberg University
University of Amsterdam
University of Auckland
TsingHua University
The University of Michigan
Miami University
DRURY University
Jilin University
Fudan University
Wuhan University
Sun Yat-sen University
Universite de Paris
Deemed University
Auckland University
The University of Tokyo
Korea University
- Trametenolic acid
Catalog No.:BCN3330
CAS No.:24160-36-9
- Febrifugine
Catalog No.:BCN3269
CAS No.:24159-07-7
- N-(4-Methylphenyl)-3-oxobutanamide
Catalog No.:BCC9058
CAS No.:2415-85-2
- Catalpol
Catalog No.:BCN5094
CAS No.:2415-24-9
- Isavuconazole
Catalog No.:BCC5515
CAS No.:241479-67-4
- TMS
Catalog No.:BCC7093
CAS No.:24144-92-1
- Khellactone
Catalog No.:BCN6684
CAS No.:24144-61-4
- 2-CMDO
Catalog No.:BCC5671
CAS No.:24140-98-5
- Flupenthixol dihydrochloride
Catalog No.:BCC7851
CAS No.:2413-38-9
- Adaphostin
Catalog No.:BCC3890
CAS No.:241127-58-2
- Sibiricaxanthone B
Catalog No.:BCN2784
CAS No.:241125-81-5
- Sibiricose A6
Catalog No.:BCN2786
CAS No.:241125-75-7
- Kobusone
Catalog No.:BCN5096
CAS No.:24173-71-5
- Zoniporide dihydrochloride
Catalog No.:BCC7461
CAS No.:241799-10-0
- H-Lys(Boc)-OH
Catalog No.:BCC2982
CAS No.:2418-95-3
- H-Glu(OtBu)-OH
Catalog No.:BCC2933
CAS No.:2419-56-9
- Boc-Glu-OH
Catalog No.:BCC3386
CAS No.:2419-94-5
- Epiyangambin
Catalog No.:BCN7029
CAS No.:24192-64-1
- Bis(4-hydroxy-3-methylphenyl) sulfide
Catalog No.:BCC8885
CAS No.:24197-34-0
- 3,3',4,4'-Benzophenone tetracarboxylic dianhydride
Catalog No.:BCC8593
CAS No.:2421-28-5
- Farrerol
Catalog No.:BCN2481
CAS No.:24211-30-1
- Tabimorelin hemifumarate
Catalog No.:BCC5897
CAS No.:242143-80-2
- Mianserin
Catalog No.:BCC4134
CAS No.:24219-97-4
- 3-Methyl-9H-carbazol-2-ol
Catalog No.:BCN4666
CAS No.:24224-30-4
Antioxidant and anticancer constituents from the leaves of Liriodendron tulipifera.[Pubmed:24705566]
Molecules. 2014 Apr 3;19(4):4234-45.
Sixteen compounds were extracted and purified from the leaves of Liriodendron tulipifera. These compounds include aporphines, oxoaporphine, coumarin, sesquiterpene lactone, benzenoids, cyclitol and steroids. (+)-Norstephalagine (2) (an aporphine) and scopoletin (8) (a coumarin) were isolated from Liriodendron tulipifera leaves from the first time. The identified compounds were screened for their antiradical scavenging, metal chelating and ferric reducing power activities. The results have showed that these compounds have antioxidative activity. The study has also examined the chemopreventive property of the isolated compounds against human melanoma cells A375. The results shown that (-)-anonaine (1), (-)-liridinine (3), (+)-lirinidine (6), lysicamine (7) and Epitulipinolide diepoxide (9) significantly inhibited the proliferation of melanoma cells. These results revealed that these compounds have antioxidative activity and chemopreventive activity in skin melanoma cells.